BioLineRx Ltd. (TLV:BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.700
-0.100 (-5.56%)
At close: Dec 4, 2025
BioLineRx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 7.91 | 10.44 | 4.26 | 10.59 | 12.99 | 16.83 | Upgrade
|
| Short-Term Investments | 17.3 | 9.13 | 38.74 | 40.5 | 44.15 | 5.76 | Upgrade
|
| Cash & Short-Term Investments | 25.21 | 19.56 | 42.99 | 51.08 | 57.14 | 22.59 | Upgrade
|
| Cash Growth | -13.58% | -54.50% | -15.83% | -10.59% | 152.95% | -17.83% | Upgrade
|
| Accounts Receivable | - | 2.48 | 0.36 | - | - | - | Upgrade
|
| Other Receivables | 0.7 | 1.39 | 0.35 | 0.72 | 0.14 | 0.14 | Upgrade
|
| Receivables | 0.7 | 3.86 | 0.71 | 0.72 | 0.14 | 0.14 | Upgrade
|
| Inventory | 2.18 | 3.15 | 1.95 | - | - | - | Upgrade
|
| Prepaid Expenses | 0.43 | 0.44 | 1.05 | 0.2 | 0.13 | 0.15 | Upgrade
|
| Other Current Assets | - | 0.09 | 0.48 | - | - | - | Upgrade
|
| Total Current Assets | 28.52 | 27.1 | 47.18 | 52 | 57.4 | 22.88 | Upgrade
|
| Property, Plant & Equipment | 0.89 | 1.35 | 1.89 | 2.5 | 2.28 | 2.7 | Upgrade
|
| Other Intangible Assets | 10.39 | 10.45 | 14.85 | 21.89 | 21.7 | 21.71 | Upgrade
|
| Total Assets | 39.8 | 38.91 | 63.93 | 76.38 | 81.39 | 47.29 | Upgrade
|
| Accounts Payable | 3.54 | 5.58 | 10.87 | 6.97 | 5.57 | 5.92 | Upgrade
|
| Accrued Expenses | 2.13 | 3.13 | 3.27 | 1.66 | 1.23 | 1.44 | Upgrade
|
| Current Portion of Long-Term Debt | 4.48 | 4.48 | 3.15 | 1.54 | 2.76 | 3.09 | Upgrade
|
| Current Portion of Leases | 0.3 | 0.52 | 0.53 | 0.43 | 0.17 | 0.19 | Upgrade
|
| Current Unearned Revenue | - | - | 12.96 | - | - | - | Upgrade
|
| Other Current Liabilities | 3.23 | 1.69 | 12.02 | 0.08 | 0 | 0 | Upgrade
|
| Total Current Liabilities | 13.67 | 15.41 | 42.78 | 10.68 | 9.72 | 10.64 | Upgrade
|
| Long-Term Debt | 5.6 | 8.96 | 6.63 | 8.63 | - | 2.74 | Upgrade
|
| Long-Term Leases | 1 | 1.08 | 1.29 | 1.73 | 1.73 | 1.66 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 4.51 | 1.86 | 10.22 | Upgrade
|
| Total Liabilities | 20.27 | 25.45 | 50.7 | 25.54 | 13.3 | 25.26 | Upgrade
|
| Common Stock | 73.43 | 38.1 | 31.36 | 27.1 | 21.07 | 9.87 | Upgrade
|
| Additional Paid-In Capital | 327.26 | 353.69 | 355.48 | 338.98 | 339.35 | 279.24 | Upgrade
|
| Retained Earnings | -399.62 | -399.83 | -390.61 | -329.99 | -305.04 | -277.99 | Upgrade
|
| Comprehensive Income & Other | 18.47 | 21.5 | 16.99 | 14.76 | 12.72 | 10.91 | Upgrade
|
| Shareholders' Equity | 19.53 | 13.46 | 13.22 | 50.84 | 68.09 | 22.03 | Upgrade
|
| Total Liabilities & Equity | 39.8 | 38.91 | 63.93 | 76.38 | 81.39 | 47.29 | Upgrade
|
| Total Debt | 11.38 | 15.04 | 11.59 | 12.32 | 4.65 | 7.68 | Upgrade
|
| Net Cash (Debt) | 13.83 | 4.52 | 31.4 | 38.76 | 52.48 | 14.9 | Upgrade
|
| Net Cash Growth | - | -85.60% | -18.98% | -26.15% | 252.17% | -12.51% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.00 | 0.03 | 0.05 | 0.08 | 0.06 | Upgrade
|
| Filing Date Shares Outstanding | 2,611 | 2,233 | 1,087 | 922.96 | 715.16 | 349.17 | Upgrade
|
| Total Common Shares Outstanding | 2,611 | 1,337 | 1,087 | 922.96 | 715.16 | 349.17 | Upgrade
|
| Working Capital | 14.86 | 11.7 | 4.4 | 41.32 | 47.69 | 12.24 | Upgrade
|
| Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.06 | 0.10 | 0.06 | Upgrade
|
| Tangible Book Value | 9.15 | 3.01 | -1.63 | 28.96 | 46.38 | 0.32 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.00 | -0.00 | 0.03 | 0.06 | 0.00 | Upgrade
|
| Machinery | - | 2.29 | 2.93 | 2.81 | 2.66 | 2.56 | Upgrade
|
| Leasehold Improvements | - | 2.04 | 2.04 | 2.04 | 2.03 | 2.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.